Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye

NCT03108664 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.

NCT NCT03108664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye
Lead sponsor
Sylentis, S.A.
Phase
Phase 3
Overall status
Completed
Start date
May 18, 2017
Completion date
November 16, 2018
Enrollment
330 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease